Marc T. Kikuchi has been with Glenmark Pharmaceuticals since 2024 and currently serves as President of Glenmark Pharmaceuticals Inc.’s North American business with responsibility for overall operations in the region. Marc is an established industry veteran with a career spanning over 3 decades.

Prior to joining Glenmark, Marc worked for Dr. Reddy’s Labs as CEO – North America Generics since 2019. He has also worked with Zydus Pharmaceuticals and AmerisourceBergen Corporation amongst other organizations in the pharmaceutical industry, having held multiple and diverse roles of increasing responsibility.

Marc is a graduate in Molecular and Cell Biology from University of California at Berkeley and a received an MBA from Carnegie Mellon University.

Rajeev Sharma is Senior Vice President Finance and Chief Financial Officer at Glenmark Pharmaceuticals Inc., USA and is responsible for managing the finance function for the North America region. Rajeev has over 25 years of experience in finance and has worked at Glenmark since 2014.

Prior to Glenmark, Rajeev worked for Ranbaxy Laboratories where he held served positions of Division, Country and Regional finance heads

Rajeev holds a Bachelor’s Degree in Commerce from Delhi University and a post-graduate degree in Cost and Management Accounting from the Institute of Cost & Works Accountants of India.

Laura Lester is Senior Vice President and General Counsel with responsibility for all legal matters in the United States and the global IPM group. She joined Glenmark in October 2020 and has been working with pharmaceutical companies on legal and compliance issues for over 20 years.

Prior to joining Glenmark, Laura was in private practice in Washington DC at Arnold & Porter Kaye Scholer LLP from 2010 to 2020 and Arent Fox LLP from 1997 to 2010. She received a J.D. from Georgetown University Law Center and a B.A. in political science from the University of Missouri.

Jim Brown is Senior Vice President, Sales and Marketing and currently leads Outside Sales, Account Services, Pricing and Analytics, Commercial Rebates, and Marketing. Jim has over 25 years’ experience in the Generic Pharmaceutical industry and was previously at Accord Healthcare in a similar role.
Jim holds a Bachelor’s degree in biology from Alma College and an MBA from the University of Colorado.

Firas Abulaban is a Senior Vice President and Corporate Quality Head of North America at Glenmark Pharmaceutical. Inc, USA and responsible for the Quality functions at Monroe, Pilar and Mahwah with focus on serving our customers, improving quality systems, and designing, manufacturing, and marketing safe and effective products that meet all customer and regulatory requirements
Firas has over 28 years of multi-disciplinary experience in Quality, Manufacturing Operations, Quality Systems and Validation / Engineering. He has expertise in Sterile manufacturing, a specialized knowledge in small and large volume Parenterals and a sound understanding of Global regulatory requirements. Firas joined Glenmark in July, 2023.
Prior to Glenmark, Firas held roles of increasing responsibility in the U.S. and internationally at PDI, Sun Pharmaceuticals, Pfizer, Hospira and Boehringer-Ingelheim responsible for leading all quality assurance, quality control and quality systems. Firas holds a Bachelor of Engineering from the Youngstown State University, Ohio, USA

Brad is Vice President Institutional Sales – North America at Glenmark Pharmaceuticals, Inc. USA with responsibility for Sales & Commercial Operations for the Institutional Business in the US. Brad joined Glenmark in February 2024 and has over 20 years of experience in pharmaceuticals across various disciplines with a focus on Sales & Marketing and Commercial Operations in the Institutional space. Prior to joining Glenmark, he held positions of responsibility with Fresenius Kabi, Hikma and Sagent Pharmaceuticals.
Brad earned a Bachelor’s Degree in Mathematics from the University of Florida and a Master’s Degree in Business from Florida State University.

Vishal Arora is Vice President of Business Development and Licensing at Glenmark Pharmaceuticals, Inc. and is responsible for all external deals relating to new products and managing US 3rd party partnerships at Glenmark for the US and Canada.
Vishal has over 15 years of North American experience in Corporate and Business Development & Portfolio Management in the Generic and Specialty Pharmaceutical areas with a focus on complex injectables, respiratory DPIs and MDIs amongst a plethora of additional dosage forms. Vishal has negotiated deals with an aggregate in-licensed value of ~ $900 million USD.
Prior to Glenmark, Vishal worked at Alvogen Pharmaceuticals, Inc., Sagent Pharmaceuticals Inc., Impax Laboratories, Banner Life Sciences and Ranbaxy USA, Inc. where he held varying positions of increasing responsibility in the commercial areas of generic and specialty pharmaceuticals.
Vishal holds a Bachelor’s degree in Chemistry from Delhi University and a Masters of Business Administration from Symbiosis University and lives in the suburbs of Chicago.

Wilfredo Ortiz is the Monroe, NC, site’s Vice President and Head. He is responsible for Operations and Quality, leveraging his more than 25 years of experience in the pharmaceutical industry. His specialization in aseptic processing and manufacturing of eye care solutions and injectables is a valuable asset to the company. Wilfredo’s journey with Glenmark began in the summer of 2021.
Before joining Glenmark, Wilfredo had diverse roles and responsibilities. Before Glenmark, Wilfredo worked at BBraun, Rani Therapeutics, and Allergan Pharmaceuticals, now Abbvie, where he spent almost 20 years of his career. During his career, he saw various aspects of the pharmaceutical industry, from manufacturing and validations to engineering, project management, and quality assurance.
Wilfredo has a Bachelor’s in Mechanical Engineering from the University of Puerto Rico, Mayaguez Campus, and an MBA from the Hankamer School of Business at Baylor University.

Adam N. Subervi is the Chief Compliance Officer of Glenmark Phamaceuticals Inc., USA (“GPI”), and is responsible for overseeing the company’s Ethics & Compliance program for all U.S. locations. Adam has been licensed to practice law for over 24 years. Prior to joining Glenmark in May 2024, Adam oversaw U.S. investigations and advised compliance leaders at Stryker (2022-20024), and served as compliance/investigations counsel at Novartis Pharmaceuticals Corporation (2017-2022). Adam is a former Assistant United States Attorney in the District of the New Jersey (2010-2017), and Deputy Attorney General/Special Assistant to the New Jersey Attorney General (2009-2010). He started his career on active duty as an officer and judge advocate in the U.S. Marine Corps, and continues to serve as a Colonel and Senior Trial Judge in the Marine Corps Reserve. Adam holds a juris doctor from Rutgers School of Law and a bachelor’s degree from Seton Hall University, and served as law clerk to the Honorable Dickinson R. Debevoise, U.S.D.J.

Fabio Moreno is the Executive Director and Head of the OTC Business at Glenmark Pharmaceuticals. Since joining the company in 2012, Fabio has held key leadership positions in operations, demand planning, supply chain and commercial across Brazil, Latin America, and North America.
With over a decade of prior entrepreneurial experience, Fabio founded and operated eight start-ups across diverse industries, giving him a unique strategic insight into business development and market dynamics. He holds a Bachelor’s Degree in Production Engineering from the Maua Institute of Technology in São Paulo, Brazil.

Karen Rocco is Executive Director Human Resources, North America. Karen is based at our Mahwah office in New Jersey, and is responsible for driving the people agenda, key initiatives & strategic objectives for the North America Commercial Business and the Monroe Manufacturing Site, North Carolina. Karen has 18 years of Pharmaceutical experience across the HR value chain and has worked for Glenmark since 2021.
Prior to joining Glenmark Karen worked for Par Pharmaceutical, an Endo International Company, where she led the HR function for Endo’s Branded and Generics manufacturing sites across North-east America. Karen brings with her, proven expertise in the areas of HR Strategy design & implementation, Performance & Talent Management, Employment Law, Talent Acquisition and Employee Relations. Karen holds a Bachelor of Science (BS) in Psychology from William Paterson University.